Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
1 other identifier
interventional
48
1 country
1
Brief Summary
Time-restricted eating (TRE) is a dietary approach that aims to increase fasting time and decrease the eating window. Promising TRE effects on weight loss and some cardiometabolic risk factors have been reported. However, there is a lack of randomized clinical trials that directly investigate the effect of TRE at different times of the day (early vs. delayed) in individuals with overweight and obesity. The present study investigates the effects of 8 weeks of TRE performed at different moments of the day on body composition and cardiometabolic parameters in adults with overweight and obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2020
CompletedFirst Submitted
Initial submission to the registry
November 14, 2020
CompletedFirst Posted
Study publicly available on registry
November 30, 2020
CompletedNovember 30, 2020
November 1, 2020
8 months
November 14, 2020
November 22, 2020
Conditions
Outcome Measures
Primary Outcomes (6)
Insulin resistance (indices)
Including but not limited to Homeostatic Model Assessment for Insulin Resistance (HOMA-IR).
Change from baseline. Measured at baseline and after 8 weeks.
Fasting insulin levels (µIU/mL)
Measured by enzyme-Linked Immunosorbent Assay
Change from baseline. Measured at baseline and after 8 weeks.
Fasting glucose levels (mg/dL)
Measured by colorimetric method
Change from baseline. Measured at baseline and after 8 weeks.
Insulin Sensitivity (indices)
Including but not limited to the Matsuda index
Change from baseline. Measured at baseline and after 8 weeks.
Glucose tolerance
Measured by oral glucose tolerance test (OGTT; 0,30,60,90, and 120 min)
Change from baseline. Measured at baseline and after 8 weeks.
Fasting lipid profile levels (mg/dL)
Measured by colorimetric method
Change from baseline. Measured at baseline and after 8 weeks.
Secondary Outcomes (15)
β cell function (indices)
Change from baseline. Measured at baseline and after 8 weeks.
Fat Mass (kg)
Change from baseline. Measured at baseline and after 8 weeks.
Fat Percentage (%)
Change from baseline. Measured at baseline and after 8 weeks.
Fat Free Mass (kg)
Change from baseline. Measured at baseline and after 8 weeks.
Body Weight (kg)
Change from baseline. Measured at baseline and after 8 weeks.
- +10 more secondary outcomes
Study Arms (3)
Early Time-Restricted Eating
EXPERIMENTAL8-hour eating window between 08:00 and 16:00
Delayed Time-Restricted Eating
EXPERIMENTAL8-hour eating window between 12:00 and 20:00
Control
EXPERIMENTAL12-hour eating window between 08:00 and 20:00
Interventions
Dietary approaches with energy restriction performed at different times of the day.
Eligibility Criteria
You may qualify if:
- Male and female;
- Body mass index (BMI) between 25 and 34.9 kg/m²;
- Age between 20 and 40 years;
- Not engaged in any structured exercise program;
- Weight stable for \~3 months prior to the beginning of the study;
- Able to give written informed consent.
You may not qualify if:
- Current smoker;
- Cardiometabolic diseases (dyslipidemia, diabetes, hypertension, etc);
- Current treatment with medication or supplements which significantly affect the main studied variables;
- Night-shift workers;
- Night eating syndrome;
- Irregular sleep patterns;
- For women: pregnancy, planned pregnancy (within the study period), lactating or menopause;
- Habitual fasting window \>16 hours;
- Concomitant participation in other studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, 90690-200, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alvaro Reischak-Oliveira
Federal University of Rio Grande do Sul
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 14, 2020
First Posted
November 30, 2020
Study Start
September 3, 2019
Primary Completion
May 12, 2020
Study Completion
May 12, 2020
Last Updated
November 30, 2020
Record last verified: 2020-11